Literature DB >> 15486600

Using Psychostimulants to Treat Depression in the Medically Ill.

Jeff C Huffman1, Theodore A Stern.   

Abstract

LESSONS LEARNED AT THE INTERFACE OF MEDICINE AND PSYCHIATRY: The Psychiatric Consultation Service at Massachusetts General Hospital (MGH) sees medical and surgical inpatients with comorbid psychiatric symptoms and conditions. Such consultations require the integration of medical and psychiatric knowledge. During their thrice-weekly rounds, Dr. Huffman and Dr. Stern discuss the diagnosis and management of conditions confronted. These discussions have given rise to rounds reports that will prove useful for clinicians practicing at the interface of medicine and psychiatry.

Entities:  

Year:  2004        PMID: 15486600      PMCID: PMC427614          DOI: 10.4088/pcc.v06n0109

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


  11 in total

1.  Methylphenidate improves HIV-1-associated cognitive slowing.

Authors:  C H Hinkin; S A Castellon; D J Hardy; R Farinpour; T Newton; E Singer
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2001       Impact factor: 2.198

Review 2.  Use of stimulants in the medically ill.

Authors:  P S Masand; G E Tesar
Journal:  Psychiatr Clin North Am       Date:  1996-09

3.  Dextroamphetamine as a treatment for depression and low energy in AIDS patients: a pilot study.

Authors:  G J Wagner; J G Rabkin; R Rabkin
Journal:  J Psychosom Res       Date:  1997-04       Impact factor: 3.006

Review 4.  Stimulants in the treatment of depression: a critical overview.

Authors:  S L Satel; J C Nelson
Journal:  J Clin Psychiatry       Date:  1989-07       Impact factor: 4.384

Review 5.  Palliative uses of methylphenidate in patients with cancer: a review.

Authors:  Mark Rozans; Albert Dreisbach; Juan J L Lertora; Marc J Kahn
Journal:  J Clin Oncol       Date:  2002-01-01       Impact factor: 44.544

6.  A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.

Authors:  W Breitbart; B Rosenfeld; M Kaim; J Funesti-Esch
Journal:  Arch Intern Med       Date:  2001-02-12

7.  Double-blind, placebo-controlled trial of methylphenidate in older, depressed, medically ill patients.

Authors:  A E Wallace; L L Kofoed; A N West
Journal:  Am J Psychiatry       Date:  1995-06       Impact factor: 18.112

Review 8.  Depression in the medically ill elderly: a focus on methylphenidate.

Authors:  R E Emptage; T P Semla
Journal:  Ann Pharmacother       Date:  1996-02       Impact factor: 3.154

9.  Methylphenidate in terminal depression.

Authors:  A D Macleod
Journal:  J Pain Symptom Manage       Date:  1998-09       Impact factor: 3.612

10.  Psychostimulants for depression in hospitalized cancer patients.

Authors:  J Olin; P Masand
Journal:  Psychosomatics       Date:  1996 Jan-Feb       Impact factor: 2.386

View more
  3 in total

1.  Prescription use disorders in older adults.

Authors:  Raj K Kalapatapu; Maria A Sullivan
Journal:  Am J Addict       Date:  2010-09-21

Review 2.  Symptom management challenges in heart failure: pharmacotherapy considerations.

Authors:  Diana Stewart; Mary Lynn McPherson
Journal:  Heart Fail Rev       Date:  2017-09       Impact factor: 4.214

3.  Adult ADHD: Questioning Diagnosis and Treatment in a Patient with Multiple Psychiatric Comorbidities.

Authors:  Robert Karoly Chu; Tea Rosic; Zainab Samaan
Journal:  Case Rep Psychiatry       Date:  2017-06-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.